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     Tyrosinase (Ec: 1.14.18.1) is a copper - containing enzyme which is distributed in all domains of life 
such as prokaryote, eukaryote, mammals, invertebrates and plants. Tyrosinase catalyzes the oxidation of 
monophenols to diphenols and diphenols to o-quinones . The tyrosinase crystallographic data shows two 
histidine -rich regions named CuA and CuB. A loop containing residues M374, S375 and V377 connects 
the CuA and CuB Centers. This loop is essential for stability of the enzyme. In this study, site directed 
mutagenesis was used for the replacement of M374 by Arginine and Lysine.in synthesized cDNA cloned 
in pET 28b (+) . These mutations don't affect the orientation of the Histidin 367(H367) side chain, 
resulting in loss of activity.  
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INTRODUCTION 
     Tyrosinase ( EC: 1.14.18.1) is the key regulatory 
enzyme that controls the initial steps of melanin 
pathway. The altered function of this enzyme is 
responsible for human oculocutaneous albinism 
(OCA). The biosynthetic pathway for melanin 
formation operating in various life forms has largely 
been elucidated . The first two steps in the pathway 
are hydroxylation of monophenol to o-diphenol 
(monophenolase or cresolase activity) and oxidation 
of diphenol to o–quinones (diphenolase or 
catecholase activity) , both using molecular oxygen 
followed by a series of non –enzymatic steps 
resulting in the formation of melanin, which plays a 
crucial protective role against skin 
photocarcinogenesis. Abnormal melanin 
pigmentation (melasma, freckles, ephelide, senile 
lentigines, etc) is a serious aesthetic problem in 
human beings [9].  Tyrosinase is copper-containing 
enzyme and is divided into three types based on 
their spectroscopic properties [1]. Individuals with 
OCAI (oculocutaneous albinism Type1) are born 
with complete absence of pigment in the skin, eyes 
and hair [2]. The catalytic center of the enzyme 
consist of hydrophobic pocked helices. Two 
histidine- rich regions named CuA and CuB are 
binding the two coppers [3]. Tyrosinase contains a 
binuclear copper complex and functions as a mono -
oxygenase and as a two-electron oxidase. Both 
copper atoms in this protein are able to bind 
oxygen. Removal of only one of the copper – 
binding histidin residues results in loss of the copper 
ions, thereby abolishing dioxygen binding and 
enzyme activity [4]. A loop containing residues 
Metheonine374 (M374), Serine375 (S375) and 
Valine377 (V377) connects the CuA and CuB 
centers. The substitutions of methionine by valine, 
leucine or isoleucine have the major effects on the 
active site that results in defects in structural 
stability of the tyrosinase polypeptides [5].  
The substitution of methionine by Aspartic acid was 
performed and Dihydorxyphenylalanine (DOPA) 
oxidase activity was highly increased [6]. Therefore, 
the present study aims at testing the ability of the 
basic aminoacid Arginine and Lysine, which 
account for substitution of methionine. Because 
these aminoacids have not previously been used , 
we analyzed the structural changes of the mutant 
tyrosinse active site for the first time by the two 
M374Arg and M374Lys mutations. 
  
MATERIAL AND METHODS 
Construction of human Tyrosinase cDNA  
     The human tyrosinase cDNA was constructed by 
eurofins mwg/operon. The nucleotide sequence of 
the human tyrosinase gene used herein is set forth in 
GenBank Accession No, NM000372. The 
constructed cDNA with 1602bp in length was 
inserted in cloning vector pCR2.1 between 
ECORI/Hind III restriction sites. 





Constructing a recombinant expression vector 
pET-hTyr 
     For this purpose, inserting the cDNA of 
human tyrosinase into a pET-28b(+)Vector to 
construct a recombinant expressions vector pET-
hTyr was performed . Preferably, a pCR2.1 
vector was digested with EcoRI/Hind III to 
release the hTyr cDNA. 
Then, the hTyr cDNA was cloned into the pET28 
b(+)vector and transformed in to E.coli 
BL21(DE3)Cells. 
Expression and purification of recombinant 
human tyrosinase  
     The recombinant human tyrosinase was 
expressed by transforming E.coli with the 
recombinant expression vector pET-hTyr and then 
culturing the transformed E.coli. 
The expression of the recombinant human 
tyrosinase was induced by the addition of 1mM 
IPTG when culture time (1, 2, 4, 6 and 8 hours) 
after addition of IPTG was investigated.  As a 
result, the best expression of tyrosinase was found 
to increase until 6 hours. The expression of 
recombinant human tyrosinc was sharply reduced 
after culturing for 8 hours (data not shown). 
Therefore, optimal expression of the recombinant 
tyrosinase in this study is induced by culturing at 
37˚C for 6 hours in 2 XYT medium (16g Tryptone , 
10 g yeast extract, 25 g Nacl) after addition of 1mM 
IPTG. The recombinant human tyrosinase was 
expressed in the form of a 6 histidine- tagged fusion 
protein in E. coli with the weight of 66 k . 
For this reason, it was preferable to purify the 
recombinant protein by anion exchange 
chromatography followed by affinity 
chromatography in a column that specifically 
absorbs these proteins. The purification was 
performed according to the kiagene protocol and the 
protein concentration of the tyrosinase was 
determined by BSA assay. BSA(bovine Serum 
albumin) as a standaral and the tyrosinase was 
incubated at 37˚C for 30 minutes. 
The standard curve produced by measuring the 
absorbance of the BSA at OD595 was used to 
determine the protein concentration of the 
tyrosinase. 
Site-directed mutagenesis 
     Site-directed mutagenesis by Quick change PCR 
was used to determine the functional role of 
Arginine and lysine residues in substitution with 
M374. In this procedure, forward and reverse 




5- CTATAGAATGGAACA AAA TCCAGGTAC -3 
Reverse primer: 
5-GTACCTGGGATTTTGTTCCATTCATATAG -3 
For Arginine : 
5-CTATATGAATGGAACA CGT TCCC AGGTAC-3 
Reverse primer: 
5-GTACCTGGACCATGTTCCATTCATATA-3  
18 cycles of denaturing at94˚c for 30s, 
 annealing at 55˚c for 30s, extension at 68˚c for 14 
min and final extension time of 10 min at 68˚c. 
Expression and purification of mutant human 
Tyrosinase 
     The mutant human Tyrosinase gene was 
expressed by transforming E.coli with the 
expression vector  pET-28(b)(+) and then culturing 
the transformed E.coli. The mutant human 
tyrosinase purification was performed by anion 
exchange chromatography in a column that 
specifically absorbs the His – Tagged proteins. 
Determination of DOPA oxidase activity  
     DOPA Oxidase activity was determined 
according to sigma protocol. 
50mM potassium phosphate Buffer, Ph 6.5, 5mM –
DOPA , 2-7 mM Ascorbic Acid solution, 0.065mM 
EDTA and tyrosinase Enzyme solution were used 
as reagents in this method . The concentration of O–
Benzoquinone formed from L-DOPA by tyrosinase 
was measured at 265nm. Specific activity of 








0.001= the change in A265nm/min per unit of 
polyphenol oxidase in a 3mol reaction mixture at 
pH 6.5 at 25c 
0.1=Volume of enzyme used 
The result is presented in Tables 1&2. 
 
RESULTS 
Human tyrosinase cDNA Analysis 
     cDNA analysis was determined with enzyme 
extracted from two cell lines named mevoo & 
skmel3. Then, cDNA was constructed by eurofins 
mwg operon (Figure 1). 
Cloning of native tyrosinase cDNA in pET 28(b) 
Native tyrosinase cDNA with 1602 bp was coloned 
into pET 28 b vector between EcoRI site and Hind 
III site to construct a recombinant expression vector 
pET-hTyr (Figure 2). This construct was 
transformed into E.coli Bl 21 (DE3) cells. The 
extracted plasmid containing the htyr cDNA was 
sequenced by Takapoozist Company (Figure 3). 
 
 





Expression of recombinant human tyrosinase 
     The recombinant human tyrosinase was 
expressed by transforming Ecoli with the pET-
htyr and then culturing the transformed E.coli.  
Then, purification of recombinant protein was 
performed as the kiagene protocol (Figure 4). The 
standard curve was used to determine the protein 
concentration of the tyrosinase (Figure 5).  
PCR quick change for mutant tyrosinase 
production 
   The Quick change PCR offers a rapid and 
reliable method for site-directed mutagenesis of 
DNA at different sites simultaneously. Site 
directed mutagenesis by quick change PCR was 
used in substitution lysine and arginine with 






















Figure 1. Nucleotide sequence of a cDNA encoding human tyrosinase in pCR2.1 vector 
 
 
Figure 2. Digestion analysis of pCR2.1 with EcoRI and Hind III for releasing a cDNA of human tyrosinase with 1602 bp in length   
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Figure 4. SDS- PAGE Analysis for translation Product of recombinant human tyrosinase gene 
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Figure 6.chromatogram for characterization of single mutation  M374LYS 
 
 





































Figure 8. SDS-PAGE Analysis for tyrosinse mutant 
proteins purification. 
Table1. DOPA oxidase activity was determined according 
to sigma protocol. The concentration of o-benzoquinone 
formed from L-DOPA by tyrosinase was measured at 
265nm in 14 minutes. 
Arg Lys  
0.258 0.260 Blank 
0.263 0.265 1 
0.275 0.283 2 
0.296 0.297 3 
0.312 0.304 4 
0.327 0.316 5 
0.343 0.337 6 
0.370 0.365 7 
0.395 0.374 8 
0.410 0.382 9 
0.425 0.409 10 
0.446 0.423 11 
0.463 0.439 12 
0.494 0.446 13 
0.533 0.455 14 
 
Table 2. Specific Activity )(
mg
Unite
 of recombinant human 
tyrosinase versus mutant tyrosinase proteins 
 (P-value is greater than 0.05) 
Recombinant Lys Arg 
593/3 278/5 423/07 
 
Expression and purification of mutant human 
tyrosinase 
    The mutant human tyrosinases were 
expressed and purified according to the protocol 
that is mentioned in materials and methods 
section (Figure 8). The mutants of human 
tyrosinase can not only be expressed stably but 
also mass-produced in E.coli. The advantage of 
this method is that the mutants of human 
tyrosinase can be expressed in E.coli without 
formation of insoluble inclusion bodies. 
DOPA Oxidase activity for mutant proteins 
Specific activity measurement was performed 
using polyphenol oxidase activity protocols. 
The conversion of L-DOPA to Benzoquinone 
was confirmed by the absorbance spectrum. No 
significant relationship between mutants and 
recombinant proteins was found. The result is 
presented in table 1 and 2. 
 
DISCUSSION 
     Tyrosinases are the first enzymes in the 
synthesis of melanin pigments responsible for 
coloring of hair, skin and eyes. Mutation of 
tyrosinases often decreases melanin production 
resulting in albinism, According to the active 
site model for tyrosinase, A loop containing 
residues M374, S375 and V377 connects the 
CuA and CuB centeres; therefore, this loop is 
essential for the stability of the active site 
structure [10]. 
This study, for the first time analyzed the 
structural changes on the mutant tyrosinase 
active site by M374 Arg and M374 Lys 
mutations. In previous studies, all kinds of 
amino acids were used to analyze the structural 
changes on the active site of tyrosinase [7]. 
Charged amino acids were not previously been 
studied. In our pervious study, a single M374 
ASP mutation was analyzed. This mutant could 
be expressed with high enzymatic activity that 
can be effectively used in medical studies [6]. 
M374 and S 375 are a part of A loop, 
connecting the two copper center CuA and CuB 
in tyrosinase active site. In human tyrosinase, 
M374 and V377 act as hydrogen acceptor and 
NH group of the imidazole ring acts as a 
hydrogen donor. The side chain of M374 
extends into the space between the two helices, 
containing the CuB binding histidines. 
Therefore, M374 arresting H367 in the right 
orientation is necessary for coordinating CuB , 
and providing a stable orientation of the 
connected tripeptide 371 N GT 373, which 
carries a glycosylation sequon [7] into the space  
between two helices containing histidine 
attached to the CuB, disturbing  the structure of  
the two helix. Arginine was obtained from the 
Arg Lys 





hyrolysis of histones. Arginine due to alkaline 
guainidine agent and R foundation is positively 
charged at physiological PH; thus, it is not able 
to accept the hydrogen of histidine imidazole 
ring. Its position on the M374 causes the lack of 
H376 bonding to CuB where loss of enzyme 
activity is high. 
Since these amino acids were previously not 
working, the results of this research will be 




      The Current research indicated the structural 
changes on the active site of tyrosinase by 
amino acids with negative charges leading to 
decrease in the activation of the enzyme. Since 
these amino acids were previously not working, 
the results of this research will be important for 
those interested in the field of enzyme activity. 
The present article is derived from a research 
project which was supported by molecular 
genetics lab in Tarbiyat Moddares University 
from 2013-2015. 
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